TY - JOUR AU - Vogelstein, B. AU - Lane, D. AU - Levine, A. J. PY - 2000 DA - 2000// TI - Surfing the p53 network JO - Nature VL - 408 UR - https://doi.org/10.1038/35042675 DO - 10.1038/35042675 ID - Vogelstein2000 ER - TY - JOUR AU - Momand, J. AU - Jung, D. AU - Wilczynski, S. AU - Niland, J. PY - 1998 DA - 1998// TI - The MDM2 gene amplification database JO - Nucleic Acids Res VL - 26 UR - https://doi.org/10.1093/nar/26.15.3453 DO - 10.1093/nar/26.15.3453 ID - Momand1998 ER - TY - JOUR AU - Oliner, J. D. AU - Kinzler, K. W. AU - Meltzer, P. S. AU - George, D. L. AU - Vogelstein, B. PY - 1992 DA - 1992// TI - Amplification of a gene encoding a p53-associated protein in human sarcomas JO - Nature VL - 358 UR - https://doi.org/10.1038/358080a0 DO - 10.1038/358080a0 ID - Oliner1992 ER - TY - JOUR AU - Pilotti, S. AU - Della, T. G. AU - Lavarino, C. AU - Di, P. S. AU - Sozzi, G. AU - Minoletti, F. PY - 1997 DA - 1997// TI - Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms JO - J Pathol VL - 181 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Pilotti1997 ER - TY - JOUR AU - Florenes, V. A. AU - Maelandsmo, G. M. AU - Forus, A. AU - Andreassen, A. AU - Myklebost, O. AU - Fodstad, O. PY - 1994 DA - 1994// TI - MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status JO - J Natl Cancer Inst VL - 86 UR - https://doi.org/10.1093/jnci/86.17.1297 DO - 10.1093/jnci/86.17.1297 ID - Florenes1994 ER - TY - JOUR AU - Henriksen, J. AU - Aagesen, T. H. AU - Maelandsmo, G. M. AU - Lothe, R. A. AU - Myklebost, O. AU - Forus, A. PY - 2003 DA - 2003// TI - Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206671 DO - 10.1038/sj.onc.1206671 ID - Henriksen2003 ER - TY - JOUR AU - Helman, L. J. AU - Meltzer, P. PY - 2003 DA - 2003// TI - Mechanisms of sarcoma development JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1168 DO - 10.1038/nrc1168 ID - Helman2003 ER - TY - CHAP AU - Brennan, M. F. AU - Singer, S. AU - Maki, R. G. AU - O'Sullivan, B. ED - DeVita, V. T. ED - Hellman, S. ED - Rosenberg, S. A. PY - 2005 DA - 2005// TI - Soft tissue sarcoma BT - Cancer Principles and Practice of Oncology PB - Lippincott Williams and Wilkins CY - Philadelphia ID - Brennan2005 ER - TY - CHAP AU - Malawer, M. M. AU - Helman, L. J. AU - O'Sullivan, B. ED - DeVita, V. T. ED - Hellman, S. ED - Maki, R. G. ED - O'Sullivan, B. PY - 2005 DA - 2005// TI - Bone Sarcoma BT - Cancer Principles and Practice of Oncology PB - Lippincott Williams and Wilkins CY - Philadelphia ID - Malawer2005 ER - TY - JOUR AU - Vassilev, L. T. AU - Vu, B. T. AU - Graves, B. AU - Carvajal, D. AU - Podlaski, F. AU - Filipovic, Z. PY - 2004 DA - 2004// TI - In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 JO - Science VL - 303 UR - https://doi.org/10.1126/science.1092472 DO - 10.1126/science.1092472 ID - Vassilev2004 ER - TY - JOUR AU - Tovar, C. AU - Rosinski, J. AU - Filipovic, Z. AU - Higgins, B. AU - Kolinsky, K. AU - Hilton, H. PY - 2006 DA - 2006// TI - Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy JO - Proc Natl Acad Sci USA VL - 103 UR - https://doi.org/10.1073/pnas.0507493103 DO - 10.1073/pnas.0507493103 ID - Tovar2006 ER - TY - JOUR AU - Coll-Mulet, L. AU - Iglesias-Serret, D. AU - Santidrian, A. F. AU - Cosialls, A. M. AU - de, F. M. AU - Castano, E. PY - 2006 DA - 2006// TI - MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-08-3273 DO - 10.1182/blood-2005-08-3273 ID - Coll-Mulet2006 ER - TY - JOUR AU - Secchiero, P. AU - Barbarotto, E. AU - Tiribelli, M. AU - Zerbinati, C. AU - di Iasio, M. G. AU - Gonelli, A. PY - 2006 DA - 2006// TI - Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-11-4465 DO - 10.1182/blood-2005-11-4465 ID - Secchiero2006 ER - TY - JOUR AU - Jiang, M. AU - Pabla, N. AU - Murphy, R. F. AU - Yang, T. AU - Yin, X. M. AU - Degenhardt, K. PY - 2007 DA - 2007// TI - Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M606928200 DO - 10.1074/jbc.M606928200 ID - Jiang2007 ER - TY - JOUR AU - Patton, J. T. AU - Mayo, L. D. AU - Singhi, A. D. AU - Gudkov, A. V. AU - Stark, G. R. AU - Jackson, M. W. PY - 2006 DA - 2006// TI - Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3 JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-3832 DO - 10.1158/0008-5472.CAN-05-3832 ID - Patton2006 ER - TY - JOUR AU - Wade, M. AU - Wong, E. T. AU - Tang, M. AU - Stommel, J. M. AU - Wahl, G. M. PY - 2006 DA - 2006// TI - Hdmx modulates the outcome of p53 activation in human tumor cells JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M605405200 DO - 10.1074/jbc.M605405200 ID - Wade2006 ER - TY - CHAP AU - Popowicz, G. M. AU - Czarna, A. AU - Rothweiler, U. AU - Sszwagierczak, A. AU - Krajewski, M. AU - Weber, L. PY - 2007 DA - 2007// TI - Molecular Basis for the Inhibition of p53 by Mdmx BT - Cell Cycle ID - Popowicz2007 ER - TY - JOUR AU - Freedman, D. A. AU - Wu, L. AU - Levine, A. J. PY - 1999 DA - 1999// TI - Functions of the MDM2 oncoprotein JO - Cell Mol Life Sci VL - 55 UR - https://doi.org/10.1007/s000180050273 DO - 10.1007/s000180050273 ID - Freedman1999 ER - TY - JOUR AU - Vassilev, L. T. PY - 2007 DA - 2007// TI - MDM2 inhibitors for cancer therapy JO - Trends Mol Med VL - 13 UR - https://doi.org/10.1016/j.molmed.2006.11.002 DO - 10.1016/j.molmed.2006.11.002 ID - Vassilev2007 ER - TY - JOUR AU - Muller, C. R. AU - Paulsen, E. B. AU - Noordhuis, P. AU - Pedeutour, F. AU - Saeter, G. AU - Myklebost, O. PY - 2007 DA - 2007// TI - Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A JO - Int J Cancer VL - 121 UR - https://doi.org/10.1002/ijc.22643 DO - 10.1002/ijc.22643 ID - Muller2007 ER - TY - JOUR AU - Cao, C. AU - Shinohara, E. T. AU - Subhawong, T. K. AU - Geng, L. AU - Woon, K. K. AU - Albert, J. M. PY - 2006 DA - 2006// TI - Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2 JO - Molecular Cancer Therapeutics VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-05-0356 DO - 10.1158/1535-7163.MCT-05-0356 ID - Cao2006 ER - TY - JOUR AU - Barbieri, E. AU - Mehta, P. AU - Chen, Z. AU - Zhang, L. AU - Slack, A. AU - Berg, S. PY - 2006 DA - 2006// TI - MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-06-0305 DO - 10.1158/1535-7163.MCT-06-0305 ID - Barbieri2006 ER - TY - JOUR AU - Stuhmer, T. AU - Chatterjee, M. AU - Hildebrandt, M. AU - Herrmann, P. AU - Gollasch, H. AU - Gerecke, C. PY - 2005 DA - 2005// TI - Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-04-1489 DO - 10.1182/blood-2005-04-1489 ID - Stuhmer2005 ER - TY - JOUR AU - Drakos, E. AU - Thomaides, A. AU - Medeiros, L. J. AU - Li, J. AU - Leventaki, V. AU - Konopleva, M. PY - 2007 DA - 2007// TI - Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2581 DO - 10.1158/1078-0432.CCR-06-2581 ID - Drakos2007 ER - TY - JOUR AU - Tabe, Y. AU - Sebasigari, D. AU - Jin, L. AU - Rudelius, M. AU - vies-Hill, T. AU - Miyake, K. PY - 2009 DA - 2009// TI - MDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-0399 DO - 10.1158/1078-0432.CCR-08-0399 ID - Tabe2009 ER - TY - CHAP AU - Zheng, T. AU - Wang, J. AU - Song, X. AU - Meng, X. AU - Pan, S. AU - Jiang, H. PY - 2010 DA - 2010// TI - Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways BT - J Cancer Res Clin Oncol ID - Zheng2010 ER - TY - JOUR AU - Carvajal, D. AU - Tovar, C. AU - Yang, H. AU - Vu, B. T. AU - Heimbrook, D. C. AU - Vassilev, L. T. PY - 2005 DA - 2005// TI - Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3576 DO - 10.1158/0008-5472.CAN-04-3576 ID - Carvajal2005 ER - TY - JOUR AU - Miyachi, M. AU - Kakazu, N. AU - Yagyu, S. AU - Katsumi, Y. AU - Tsubai-Shimizu, S. AU - Kikuchi, K. PY - 2009 DA - 2009// TI - Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-2955 DO - 10.1158/1078-0432.CCR-08-2955 ID - Miyachi2009 ER - TY - JOUR AU - Minotti, G. AU - Menna, P. AU - Salvatorelli, E. AU - Cairo, G. AU - Gianni, L. PY - 2004 DA - 2004// TI - Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity JO - Pharmacol Rev VL - 56 UR - https://doi.org/10.1124/pr.56.2.6 DO - 10.1124/pr.56.2.6 ID - Minotti2004 ER - TY - JOUR AU - Siddik, Z. H. PY - 2003 DA - 2003// TI - Cisplatin: mode of cytotoxic action and molecular basis of resistance JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206933 DO - 10.1038/sj.onc.1206933 ID - Siddik2003 ER - TY - JOUR AU - Perego, P. AU - Corna, E. AU - De, C. M. AU - Gatti, L. AU - Polizzi, D. AU - Pratesi, G. PY - 2001 DA - 2001// TI - Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines JO - Curr Med Chem VL - 8 UR - https://doi.org/10.2174/0929867013373994 DO - 10.2174/0929867013373994 ID - Perego2001 ER - TY - JOUR AU - Pedeutour, F. AU - Forus, A. AU - Coindre, J. M. AU - Berner, J. M. AU - Nicolo, G. AU - Michiels, J. F. PY - 1999 DA - 1999// TI - Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors JO - Genes Chromosomes Cancer VL - 24 UR - https://doi.org/3.0.CO;2-P DO - 3.0.CO;2-P ID - Pedeutour1999 ER - TY - JOUR AU - Roberts, W. M. AU - Douglass, E. C. AU - Peiper, S. C. AU - Houghton, P. J. AU - Look, A. T. PY - 1989 DA - 1989// TI - Amplification of the gli gene in childhood sarcomas JO - Cancer Res VL - 49 ID - Roberts1989 ER - TY - JOUR AU - Berg, M. AU - Agesen, T. H. AU - Thiis-Evensen, E. AU - Merok, M. A. AU - Teixeira, M. R. AU - Vatn, M. H. PY - 2010 DA - 2010// TI - Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci JO - Mol Cancer VL - 9 UR - https://doi.org/10.1186/1476-4598-9-100 DO - 10.1186/1476-4598-9-100 ID - Berg2010 ER - TY - JOUR AU - Keepers, Y. P. AU - Pizao, P. E. AU - Peters, G. J. AU - van Ark-Otte, J. AU - Winograd, B. AU - Pinedo, H. M. PY - 1991 DA - 1991// TI - Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing JO - Eur J Cancer VL - 27 UR - https://doi.org/10.1016/0277-5379(91)90142-Z DO - 10.1016/0277-5379(91)90142-Z ID - Keepers1991 ER - TY - JOUR AU - Chou, T. C. AU - Talalay, P. PY - 1984 DA - 1984// TI - Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors JO - Adv E,nzyme Regul VL - 22 UR - https://doi.org/10.1016/0065-2571(84)90007-4 DO - 10.1016/0065-2571(84)90007-4 ID - Chou1984 ER - TY - JOUR AU - Chou, T. C. PY - 2006 DA - 2006// TI - Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies JO - Pharmacol Rev VL - 58 UR - https://doi.org/10.1124/pr.58.3.10 DO - 10.1124/pr.58.3.10 ID - Chou2006 ER - TY - JOUR AU - Masuda, H. AU - Miller, C. AU - Koeffler, H. P. AU - Battifora, H. AU - Cline, M. J. PY - 1987 DA - 1987// TI - Rearrangement of the p53 gene in human osteogenic sarcomas JO - Proc Natl Acad Sci USA VL - 84 UR - https://doi.org/10.1073/pnas.84.21.7716 DO - 10.1073/pnas.84.21.7716 ID - Masuda1987 ER - TY - JOUR AU - Felix, C. A. AU - Kappel, C. C. AU - Mitsudomi, T. AU - Nau, M. M. AU - Tsokos, M. AU - Crouch, G. D. PY - 1992 DA - 1992// TI - Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma JO - Cancer Res VL - 52 ID - Felix1992 ER - TY - JOUR AU - Joensuu, H. AU - Fletcher, C. AU - Dimitrijevic, S. AU - Silberman, S. AU - Roberts, P. AU - Demetri, G. PY - 2002 DA - 2002// TI - Management of malignant gastrointestinal stromal tumours JO - Lancet Oncol VL - 3 UR - https://doi.org/10.1016/S1470-2045(02)00899-9 DO - 10.1016/S1470-2045(02)00899-9 ID - Joensuu2002 ER - TY - JOUR AU - Andreassen, A. AU - Oyjord, T. AU - Hovig, E. AU - Holm, R. AU - Florenes, V. A. AU - Nesland, J. M. PY - 1993 DA - 1993// TI - p53 abnormalities in different subtypes of human sarcomas JO - Cancer Res VL - 53 ID - Andreassen1993 ER - TY - JOUR AU - Korotchkina, L. G. AU - Demidenko, Z. N. AU - Gudkov, A. V. AU - Blagosklonny, M. V. PY - 2009 DA - 2009// TI - Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.22.10121 DO - 10.4161/cc.8.22.10121 ID - Korotchkina2009 ER - TY - JOUR AU - Toledo, F. AU - Wahl, G. M. PY - 2007 DA - 2007// TI - MDM2 and MDM4: p53 regulators as targets in anticancer therapy JO - Int J Biochem Cell Biol VL - 39 UR - https://doi.org/10.1016/j.biocel.2007.03.022 DO - 10.1016/j.biocel.2007.03.022 ID - Toledo2007 ER - TY - JOUR AU - Hu, B. AU - Gilkes, D. M. AU - Farooqi, B. AU - Sebti, S. M. AU - Chen, J. PY - 2006 DA - 2006// TI - MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.C600147200 DO - 10.1074/jbc.C600147200 ID - Hu2006 ER - TY - JOUR AU - Kitagawa, M. AU - Aonuma, M. AU - Lee, S. H. AU - Fukutake, S. AU - McCormick, F. PY - 2008 DA - 2008// TI - E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.164 DO - 10.1038/onc.2008.164 ID - Kitagawa2008 ER - TY - JOUR AU - Lau, L. M. AU - Nugent, J. K. AU - Zhao, X. AU - Irwin, M. S. PY - 2008 DA - 2008// TI - HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function JO - Oncogene VL - 27 UR - https://doi.org/10.1038/sj.onc.1210707 DO - 10.1038/sj.onc.1210707 ID - Lau2008 ER - TY - JOUR AU - Michaelis, M. AU - Rothweiler, F. AU - Klassert, D. AU - von, D. A. AU - Weber, K. AU - Fehse, B. PY - 2009 DA - 2009// TI - Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3 JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-1856 DO - 10.1158/0008-5472.CAN-08-1856 ID - Michaelis2009 ER - TY - JOUR AU - Ambrosini, G. AU - Sambol, E. B. AU - Carvajal, D. AU - Vassilev, L. T. AU - Singer, S. AU - Schwartz, G. K. PY - 2007 DA - 2007// TI - Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1 JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210136 DO - 10.1038/sj.onc.1210136 ID - Ambrosini2007 ER - TY - JOUR AU - Peirce, S. K. AU - Findley, H. W. PY - 2009 DA - 2009// TI - The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73 JO - Int J Oncol VL - 34 ID - Peirce2009 ER - TY - JOUR AU - Banerjee, D. AU - Mayer-Kuckuk, P. AU - Capiaux, G. AU - Budak-Alpdogan, T. AU - Gorlick, R. AU - Bertino, J. R. PY - 2002 DA - 2002// TI - Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase JO - Biochim Biophys Acta VL - 1587 UR - https://doi.org/10.1016/S0925-4439(02)00079-0 DO - 10.1016/S0925-4439(02)00079-0 ID - Banerjee2002 ER - TY - JOUR AU - DeGregori, J. AU - Kowalik, T. AU - Nevins, J. R. PY - 1995 DA - 1995// TI - Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes JO - Mol Cell Biol VL - 15 UR - https://doi.org/10.1128/MCB.15.8.4215 DO - 10.1128/MCB.15.8.4215 ID - DeGregori1995 ER - TY - JOUR AU - Aslanian, A. AU - Iaquinta, P. J. AU - Verona, R. AU - Lees, J. A. PY - 2004 DA - 2004// TI - Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics JO - Genes Dev VL - 18 UR - https://doi.org/10.1101/gad.1196704 DO - 10.1101/gad.1196704 ID - Aslanian2004 ER - TY - JOUR AU - Francoz, S. AU - Froment, P. AU - Bogaerts, S. AU - De, C. S. AU - Maetens, M. AU - Doumont, G. PY - 2006 DA - 2006// TI - Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo JO - Proc Natl Acad Sci USA VL - 103 UR - https://doi.org/10.1073/pnas.0508476103 DO - 10.1073/pnas.0508476103 ID - Francoz2006 ER - TY - JOUR AU - Maguire, M. AU - Nield, P. C. AU - Devling, T. AU - Jenkins, R. E. AU - Park, B. K. AU - Polanski, R. PY - 2008 DA - 2008// TI - MDM2 regulates dihydrofolate reductase activity through monoubiquitination JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5271 DO - 10.1158/0008-5472.CAN-07-5271 ID - Maguire2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/11/211/prepub UR - http://www.biomedcentral.com/1471-2407/11/211/prepub ID - ref55 ER -